Highlights


Publication of Third Quarter 2014 results

Publication of Third Quarter 2014 results

Q3 2014 Consensus Estimates

Q3 2014 Consensus Estimates


The company is covered by various German and international financial analysts.  

 

The analyst consensus for Q3 2014 is given here.


2015 All-Europe Executive Team

2015 All-Europe Executive Team

The Institutional Investor 2015 All-Europe Executive Team survey has started.  Both buyside and sellside will give their views on the IR performance of quoted companies, executives and individual IR professionals.

We would appreciate it, if you participate within the 2015 All-Europe Executive Team survey and vote for Bayer.

If you have not received a ballot from Institutional Investor yet, you can request it here.


September 30, 2014: Meet Management in London

September 30, 2014: Meet Management in London

On September 30, 2014 we have hosted our Meet Management Conference for investors and analysts in London.

With presentations by
Dr. Marijn Dekkers, CEO of Bayer AG and
Prof. Dr. Andreas Busch, Head of Global Drug Discovery

On-demand audio recording of the presentations

Meet Management Investor Handout
Download ( PDF, 2 MB )collect

 

 


Ad-hoc Announcement according to § 15 WpHG

Ad-hoc Announcement according to § 15 WpHG

Strategic corporate decision:
Bayer plans to focus entirely on Life Science businesses

Download ( PDF, 29 KB )collect


Q2 2014 All in One Package for Investors and Analysts

Q2 2014 All in One Package for Investors and Analysts

Service for Investors and Analysts:
Download all documents on our Second Quarter 2014 results in one ZIP file:
 
Download ( ZIP, 5 MB )collect

Last updated: October 24, 2014 Copyright © Bayer AG